samedan logo
 
 
 
spacer
home > ebr > spring 2003 > utility, inventiveness and patenting dna
PUBLICATIONS
European Biopharmaceutical Review

Utility, Inventiveness and Patenting DNA

In July 2002 a group of leading scientists and lawyers looked in detail at the sometimes vexed question of patents that relate to claims involving DNA and genetic technology in general. The Nuffield Council on Bioethics comprehensively reviewed the interaction of ethical issues, with both the law of patents and its practical impact upon research and development, in the discussion paper The Ethics of Patenting DNA (1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Brian Cain, Solicitor with Richards Butler

Brian Cain is a solicitor currently practising with Richards Butler. Brian is the author of Legal Aspects of Gene Technology, a new book published by Sweet & Maxwell dealing with issues ranging from potential liabilities arising out of the release or marketing of GM products to protecting the intellectual property in GM technology.

He holds a Law degree from Bristol University and a degree in Biological Sciences from the University of London.

spacer
Brian Cain
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Continues to Drive Innovation in Virtualization for Respiratory Clinical Trials

ERT, the global leader in clinical endpoints data collection, today announced a strategic partnership with Inofab Health, a healthcare technology company designing and developing ultrasonic spirometry technology for in-clinic and at-home use.
More info >>

White Papers

PhlexEarchive: The Right Solution for Electronic Archiving of TMF Content

Phlexglobal Ltd

Many sponsor organizations have already recognized the value of moving from paper to electronic Trial Master Files (eTMFs). But few sponsors have taken a more holistic approach to the TMF lifecycle and looked at the entire process from study start-up through archiving of the TMF in electronic format, also known as e-archiving. The recurring value of managing, tracking, maintaining and accessing electronic files should not stop at the point of archiving. All of the challenges of managing an active paper TMF carry through to a paper archive. All of the benefits of an electronic TMF also carry through to the electronic archive. As companies look to move their compliance assets to secure, long-term storage, it is important to consider ongoing compliance requirements, security, accessibility, efficiency and costs of archiving TMF content in a digital format.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement